41% of Americans will not get the flu shot this season, survey finds

6 December 2018

A new survey from NORC at the University of Chicago finds that two-thirds of adults in the USA do not intend to get the flu vaccine this season.

The poll, which included more than 1,000 adults, found that while 43% of adults had gotten a flu vaccination already, and another 14% had a firm intention of doing so, 41% said they would not get the flu shot.

The survey will raise concerns among healthcare providers and lawmakers that, despite continued investment from the pharmaceutical industry in novel vaccines, a lack of support for regular vaccinations could limit herd immunity and restrict efficacy.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK